Dadia, Roldan D.
HRN: 12-80-42 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/03/2022
AMOXICILLIN 250MG/5ML, 60ML SUSPENSION (BOT)
06/03/2022
06/10/2022
PO
5ml
Q8
PCAP
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes